65. In regulation 8(1) of the Medicines (Administration of Radioactive Substances) Regulations 1978 M1—U.K.
(a)for “Section 6(2) of the Act” substitute “Regulation 6(3) of the Human Medicines Regulations 2012 (“the 2012 Regulations”); and
(b)for “by or under the Act” substitute “ by the 2012 Regulations ”.
Marginal Citations
M1S.I. 1978/1006, as amended by S.I. 1995/2147 and S.I. 2006/2407. There are other amendments, but none is relevant.
66. In the Schedule to the Importation of Animal Products and Poultry Products Order 1980 M2, for “or the Medicines for Human Use (Marketing Authorisations Etc. Regulations) 1994” substitute “ or the Human Medicines Regulations 2012 ”.U.K.
Marginal Citations
M2S.I. 1980/14, as amended by S.I. 1994/2920, S.I. 1994/3142 and S.I. 1994/3144.
67. In rule 2 of The Medicines Act (Hearings by Persons Appointed) Rules 1986 M3—U.K.
(a)in the definition “applicant” omit the words “a licence or certificate under Part II or a direction under section 47(6) (application for a direction concerning incorporation of standard conditions into a licence or certificate) or”;
(b)in the definition “person appointed” omit—
(i)sub-paragraphs (i), (ii), (iii), (v) and (vi), and
(ii)the words following sub-paragraph (vii), from “including” until the end of the definition; and
(c)in the definition “relevant Minister”—
(i)omit sub-paragraph (i), and
(ii)in sub-paragraph (ii) for “the appropriate Ministers as defined in section 1(2)” substitute “ the Ministers as defined in regulation 6(6) and (7) (the licensing authority and the Ministers) of the Human Medicines Regulations 2012 ”.
Marginal Citations
M3S.I. 1986/1700. There are amendments, but none is relevant.
68. In rule 2 of The Medicines Act (Hearings by Persons Appointed) Rules 1986 M4—U.K.
(a)in the definition “applicant” omit the words “a licence or certificate under Part II or a direction under section 47(6) (application for a direction concerning incorporation of standard conditions into a licence or certificate) or”;
(b)in the definition “person appointed” omit—
(i)sub-paragraphs (i), (ii), (iii), (v) and (vi), and
(ii)the words following sub-paragraph (vii), from “including” until the end of the definition; and
(c)in the definition “relevant Minister”—
(i)omit sub-paragraph (i), and
(ii)in sub-paragraph (ii) for “section 1(1)” substitute “ regulation 6(6) and (7) (the licensing authority and the Ministers) of the Human Medicines Regulations 2012 ”.
Marginal Citations
M4S.I. 1986/1761, as amended by S.I. 2006/2407. There are other amendments, but none is relevant.
69.—(1) The Medicines (Fixing of Fees Relating to Medicinal Products for Human Use) Order 1989 M5 is amended as follows.U.K.
(2) In article 1(2) insert after the definition “ the 1987 Act ” the following definition—
““the 2012 Regulations” means the Human Medicines Regulations 2012;”.
(3) In Schedule 1—
(a)in paragraph 1 omit “, II” and “, VI”;
(b)after paragraph 1 insert the following paragraph—
“1A. Functions of the Ministers under the 2012 Regulations (except those under Part 15 (British Pharmacopeia) of those Regulations), subject to paragraph 11 below.”.
(c)in paragraph 2 for “Part II of the 1968 Act “ substitute “Parts 3 to 8 of the 2012 Regulations”;
(d)for paragraph 3 substitute—
“3. Functions of the Commission on Human Medicines, whose continuation is provided for in regulation 9 of the 2012 Regulations (except those under Part 15 (British Pharmacopoeia) of those Regulations).”;
(e)for paragraph 4 substitute—
“4. Functions of any expert committee appointed by the licensing authority under the 2012 Regulations.”.
(f)for paragraph 8 substitute—
“8. Functions of reviewers appointed under the 2012 Regulations.”.
(g)omit paragraphs 9A, 9C and 9D;
(h)in paragraph 10(c) for “and of the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994” substitute “ and of the 2012 Regulations ” and
(i)in paragraph 11—
(i)after “Paragraphs 1” insert “ , 1A ”, and
(ii)after “under it” insert “ or under the 2012 Regulations ”.
Marginal Citations
M5S.I. 1989/684, as amended by S.I. 1995/871, S.I. 2004/1031 and S.I. 2005/2754. There are other amendments, but none is relevant.
70. In regulation 1(2) of the Medical Devices (Consultation Requirements) (Fees) Regulations 1995 M6—U.K.
(a)in the definition “authorised medicinal product”—
(i)in sub-paragraph (b) before “under” insert “ the Human Medicines Regulations 2012 or ”, and
(ii)in sub-paragraph (c) for “those” substitute “ the latter ”; and
(b)in the definition “product licence of right” for “section 25(4) of that Act” substitute “ paragraph 3(2) of Schedule 32 to the Human Medicines Regulations 2012 ”.
Marginal Citations
71.—(1) The Prescription Only Medicines (Human Use) Order 1997 M7 is amended as follows.U.K.
(2) In article 1—
(a)in paragraph (2) omit all the defined expressions except “inhaler” and “maximum strength”;
(b)for paragraph (2A) substitute—
“(2A) In this Order, unless the context otherwise requires, any expression defined by any provision of the Human Medicines Regulations 2012 has the same meaning as it has for the purposes of those Regulations.”;
(c)in paragraph (5) for “Schedules 1, 2, 3A and 5” substitute “ Schedules 1 and 2 ”; and
(d)omit paragraphs (6) to (9).
(3) In article 5(1) for the words from the beginning of the paragraph until sub-paragraph (a) substitute “A medicinal product that is not the subject of a marketing authorisation is a prescription only medicine for the purposes of the Human Medicines Regulations 2012 if it, or a substance in it, is listed in column 1 of Schedule 1, unless there”.
(4) In paragraphs (1) and (2) of article 10 for the words “The restrictions” to “administration of” substitute “ A medicinal product is not a prescription only medicine for the purposes of the Human Medicines Regulations 2012 by virtue of Article 5(1) if it is ”.
Marginal Citations
M7S.I. 1997/1830, as amended by S.I. 1997/2044, S.I. 1998/108, S.I. 1998/1178, S.I. 1998/2081, S.I. 1999/1044, S.I. 1999/3463, S.I. 2000/1917, S.I. 2000/2899, S.I. 2000/3231, S.I. 2001/2777, S.I. 2001/3942, S.I. 2003/696, and S.I. 2006/915. There are other amendments, but none is relevant.
72. In rule 7B(b) of the Schedule to the General Optical Council (Rules relating to Injury or Disease of the Eye) Order of Council 1999 M8, for the words from “article” to the end of the paragraph substitute “ regulation 215 (prescribing and administration by supplementary prescribers) ” of the Human Medicines Regulations 2012.U.K.
Marginal Citations
M8S.I. 1999/3267, as amended by S.I. 2005/1476. There are other amendments, but none is relevant.
73. The National Health Service (Charges for Drugs and Appliances) Regulations 2000 M9 are amended as follows—U.K.
F1(a). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b)in regulation 6A(6) for the words from “the Medicines” to the end of the paragraph substitute “ the Human Medicines Regulations 2012 ”.
Textual Amendments
F1Sch. 34 para. 73(a) revoked (E.) (1.4.2015) by The National Health Service (Charges for Drugs and Appliances) Regulations 2015 (S.I. 2015/570), reg. 1, Sch. 3
Marginal Citations
M9S.I. 2000/620, as amended by S.I. 2000/3189 and S.I. 2009/1166. There are other amendments, but none is relevant.
74. In Schedule 2 to the Biocidal Products Regulations 2001 M10—U.K.
(a)omit entry (f); and
(b)for entry (i) substitute—
“(i)the Human Medicines Regulations 2012;”.
Marginal Citations
M10S.I. 2001/880, as amended by S.I. 2010/745. There are other amendments, but none is relevant.
75. In article 4(4) of the Medicines (Aristolochia and Mu Tong etc) (Prohibition Order) 2001 M11, for the words following “marketing authorisation” to the end of the paragraph substitute “ , certificate of registration, traditional herbal registration or Article 126a authorisation within the meaning of the Human Medicines Regulations 2012. ”U.K.
Marginal Citations
M11S.I. 2001/1841, as amended by S.I. 2005/2750 and S.I. 2008/548.
76. In regulation 2(1) of the Misuse of Drugs Regulations 2001 M12—U.K.
(a)in the definitions “clinical management plan”, “nurse independent prescriber”, “patient group direction”, “pharmacist independent prescriber”, “registered chiropodist”, “registered midwife”, “registered nurse”, “registered occupational therapist”, “registered optometrist”, “registered orthoptist”, “registered orthotist and prosthetist”, “registered paramedic”, “registered physiotherapist”, “registered radiographer” and “supplementary prescriber”, for “the Prescription Only Medicines (Human Use) Order 1997” substitute “ the Human Medicines Regulations 2012 ”; and
(b)in the definitions “pharmacist” and “registered pharmacy” for “the Medicines Act 1968” substitute “ the Human Medicines Regulations 2012 ”.
Marginal Citations
M12S.I. 2001/3998, as amended by S.I. 2003/2429, S.I. 2005/271, S.I. 2006/986, S.I. 2006/1450, S.I. 2007/2154 and 2012/973. There are other amendments, but none is relevant.
77. In paragraph (d) of article 3 of the Medicines for Human Use (Kava-kava) (Prohibition Order) 2002 M13, for the words following “subject” to the end of the article substitute “ of a marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation within the meaning of the Human Medicines Regulations 2012. ”.U.K.
Marginal Citations
M13S.I. 2002/3170, as amended by S.I. 2005/2750 and S.I. 2008/548.
F278. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.K.
Textual Amendments
79. In the column “specified UK laws” of the Schedule to the Enterprise Act 2002 (Part 8 Community Infringements Specified UK Laws) Order 2003 M14 for “the Medicines (Advertising) Regulations 1994” substitute “ Chapters 1 and 2 of Part 14 (advertising) of the Human Medicines Regulations 2012 ”.U.K.
Marginal Citations
M14S.I. 2003/1374. There are amendments, but none is relevant.
80. In the Schedule to the Enterprise Act 2002 (Part 8 Notice to OFT of Intended Prosecution Specified Enactments, Revocation and Transitional Provision) Order 2003 M15—U.K.
(a)in the first column, insert in the appropriate position in alphabetical order “ Human Medicines Regulations 2012 ”;
(b)in the second column, insert adjacent to the entry “ Human Medicines Regulations 2012 ” in the first column “regulation 303 (advertising offences)”; and
(c)omit “Medicines (Advertising) Regulations 1994” in the first column and the adjacent entry “regulation 23 (offences)” in the second column.
Marginal Citations
M15S.I. 2003/1376. There are amendments, but none is relevant.
81. In article 6 of the Health Professions (Parts of and Entries in the Register) Order of Council 2003 M16—U.K.
(a)for sub-paragraph (b) of paragraph (2), up to and including the word “analgesics”, substitute—
“(b)referred to in the following provisions of Schedule 17 (exemption for sale, supply or administration by certain persons) to the Human Medicines Regulations 2012 —
(i)in Part 1 (exemption from restrictions on sale or supply of prescription only medicines), paragraph 11 (certificate of competence in the use of specified medicines), or
(ii)in Part 3 (exemptions from the restriction on administration of prescription only medicines), paragraph 1 (certificate in the use of analgesics),”; and
(b)in paragraph (3) for “the Prescription Only Medicines (Human Use) Order 1997” substitute “ the Human Medicines Regulations 2012 ”.
Marginal Citations
M16S.I. 2003/1571, as amended by S.I. 2006/1996. There are other amendments, but none is relevant.
82.—(1) The Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003 M17 (interpretation) are amended as follows.U.K.
(2) In regulation 1(2)—
(a)omit the following definitions—
(i)“the 1994 Regulations”, and
(ii)“herbal remedy”;
(b)before the definition of “the appropriate committee” insert—
““the 2012 Regulations” means the Human Medicines Regulations 2012;”.
(c)for the definition of “the appropriate committee” substitute—
““the appropriate committee” means whichever the appropriate Minister considers to be the appropriate body of the following—
the Commission; or
an expert committee appointed by the appropriate Minister, or by the appropriate Ministers for Great Britain and for Northern Ireland acting jointly;”;
(d)after the definition of “the appropriate Minister” insert—
““the Commission” means the Commission on Human Medicines continued in existence by regulation 9 of the 2012 Regulations;”;
(e)for the definition of “excluded medicine” substitute—
““excluded medicine” means a medicinal product to which the restrictions in regulation 46 (requirement for authorisation) of the 2012 Regulations do not apply by virtue of regulation 3(6) (scope of these Regulations: special provisions) or 4(1) (special provisions for pharmacies etc) of those Regulations;”;
(f)in the definition of “market” for the words from “have the same meaning” to the end substitute “ are to be construed in accordance with the 2012 Regulations; ”;
(g)for the definition of “medicinal product” substitute—
““medicinal product” has the meaning given by regulation 2 of the 2012 Regulations;”; and
(h)in the definition of “unlicensed product”—
(i)in paragraph (a)(i), for “the 1994 Regulations” substitute “ the 2012 Regulations ”,
(ii)omit paragraph (b) and the word “or” following it,
(iii)for paragraph (c) substitute—
“(c)no traditional herbal registration has been granted by the licensing authority under the 2012 Regulations;”, and
(iv)after that paragraph insert the word “ or ” and the following paragraph —
“(d)no Article 126a authorisation has been granted by the licensing authority under those regulations;”.
Marginal Citations
M17S.I. 2003/1680, as amended by S.I. 2004/3224, S.I. 2005/2750 and S.I. 2005/2754.
83.—(1) The National Health Service (General Medical Services Contracts) (Scotland) Regulations 2004 M18 are amended as follows.U.K.
(2) In regulation 2(1)—
(a)omit the definition “the POM Order”; and
(b)in the definition “prescription only medicine” for the words from “article” to the end of the definition substitute “ regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012 ”.
(3) In paragraph 41(2)(a) of Schedule 5—
(a)for “article 3B(3) of the POM Order” substitute “ regulation 215 of the Human Medicines Regulations 2012 ”; and
(b)for “that Order” substitute “ those Regulations ”.
Marginal Citations
M18S.S.I. 2004/115, as amended by S.S.I. 2005/337. There are other amendments, but none is relevant.
84.—(1) The National Health Service (Primary Medical Services Section 17C Agreements) (Scotland) Regulations 2004 M19 are amended as follows.U.K.
(2) In regulation 2(1)—
(a)omit the definition “the POM Order”; and
(b)in the definition “prescription only medicine” for the words from “article” to the end of the definition substitute “ regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012 ”.
(3) In paragraph 13(2)(a) of Schedule 1—
(a)for “article 3B(3) of the POM Order” substitute “ regulation 215 of the Human Medicines Regulations 2012 ”; and
(b)for “that Order” substitute “ those Regulations ”.
Marginal Citations
M19S.S.I. 2004/116, as amended by S.S.I. 2005/336. There are other amendments, but none is relevant.
F385. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.K.
Textual Amendments
F3Sch. 34 para. 85 revoked (E.) (7.12.2015) by The National Health Service (General Medical Services Contracts) Regulations 2015 (S.I. 2015/1862), reg. 1(2), Sch. 5 (with reg. 2)
86.—(1) The National Health Service (General Medical Services Contracts) (Wales) Regulations 2004 M20 are amended as follows.U.K.
(2) In regulation 2—
(a)in paragraph (1)—
(i)omit the definition “the POM Order”; and
(ii)in the definition “prescription only medicine” for the words from “article” to the end of the definition substitute “ regulation 5(3) (classification of medicinal products) of the Human Medicines Regulations 2012 ”; and
(b)in paragraph (3) for “the POM Order” substitute “ the Human Medicines Regulations 2012 ”.
(3) In paragraph 43(2)(a) of Schedule 6—
(a)for “article 3B(3) of the POM Order” substitute “ regulation 215 of the Human Medicines Regulations 2012 ”; and
(b)for “that Order” substitute “ those Regulations ”.
Marginal Citations
M20S.I. 2004/478, as amended by S.I. 2006/358 and S.I. 2010/1647. There are other amendments, but none is relevant.
F487. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .U.K.
Textual Amendments
88. In Schedule 2 to the National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004 M21 for “article 12F of the Prescription Only Medicines (Human Use) Order 1997 or article 8 of the Medicines (Pharmacy and General Sale- Exemptions) Order 1980”, in both places where those words occur, substitute “ regulation 247 (exemption for supply in the event or anticipation of pandemic disease) of the Human Medicines Regulations 2012 ”.U.K.
Marginal Citations
M21S.I. 2004/1022, as amended by S.I 2005/366 and S.I. 2009/1977. There are other amendments, but none is relevant.
89.—(1) The Contracting Out (Functions relating to Broadcast Advertising) and Specification of Relevant Functions Order 2004 M22 is amended as follows.U.K.
(2) In article 2(1)—
(a)omit the definition “the 1994 Regulations”; and
(b)after the definition “the 2003 Act” insert the following definition—
““the 2012 Regulations” means the Human Medicines Regulations 2012;”.
(3) In article 7—
(a)in paragraph (1) for “the 1994 Regulations” substitute “ Chapter 3 (monitoring of advertising) of Part 14 of the 2012 Regulations ”; and
(b)in paragraph (2)—
(i)for “the 1994 Regulations” substitute “ the 2012 Regulations ”, and
(ii)for the words from “the following” to the end of the paragraph substitute “ regulation 314 of the 2012 Regulations ”.
(4) In article 8(3)(d) for “the 1994 Regulations” substitute “ Chapter 3 (monitoring of advertising) of Part 14 of the 2012 Regulations ”.
(5) In article 11—
(a)in paragraph (2) for “the 1994 Regulations” substitute “ the 2012 Regulations ”; and
(b)in paragraph (3)—
(i)for “section 1(1)(a) of the Medicines Act 1968” substitute “ regulation 6(6) of the 2012 Regulations ”, and
(ii)for “the 1994 Regulations” substitute “ Chapter 3 (monitoring of advertising) of Part 14 of the 2012 Regulations ”.
Marginal Citations
90. In the Table in rule 10 of the Schedule to the General Optical Council (Registration Rules) Order of Council 2005 M23—U.K.
(a)in entry B column 3—
(i)in paragraph (a) for “paragraph 6A of Schedule 5 to the Prescription Only Medicines (Human Use) Order 1997” substitute “ paragraph 8 of Part 1 of Schedule 17 of the Human Medicines Regulations 2012 ”, and
(ii)in paragraph (b) for “6B” substitute “ 9 ”;
(b)in entry C column 3 for “article 3B of the Prescription Only Medicines (Human Use) Order 1997” substitute “ regulation 215 of the Human Medicines Regulations 2012 ”; and
(c)in entry D column 3 for “article 3 of the Prescription Only Medicines (Human Use) Order 1997” substitute “ regulation 5(3) of the Human Medicines Regulations 2012 ”.
Marginal Citations
M23S.I. 2005/1478, as amended by S.I. 2008/1940. There are other amendments, but none is relevant.
91.—(1) The National Health Service (Free Prescriptions and Charges for Drugs and Appliances) (Wales) Regulations 2007 M24 are amended as follows.U.K.
(2) In regulation 2(1) omit the definition of “the POM Order”.
(3) In regulation 2(2A) for “the POM Order” substitute “ the Human Medicines Regulations 2012 ”.
(4) In regulation 7(2) for the words from “the Medicines” to the end of the regulation substitute “ the Human Medicines Regulations 2012 ”.
(5) In regulation 7A(1)(b) for the words from “article 12F” to the end of the regulation substitute “ regulation 247 of the Human Medicines Regulations 2012 ”.
Marginal Citations
M24S.I. 2007/121, as amended by S.I. 2009/1175 and S.I. 2010/1647. There are other amendments, but none is relevant.
92. In regulation 2(3) of the Human Tissue (Quality and Safety for Human Application) Regulations 2007 M25—U.K.
(a)omit sub-paragraph (a); and
(b)for sub-paragraph (b) substitute—
“(b)the Human Medicines Regulations 2012;”.
Marginal Citations
93.—(1) The Schedule to the Legislative and Regulatory Reform (Regulatory Functions) Order 2007 M26 is amended as follows.U.K.
(2) In Part 2 under the heading “Medicines”—
(a)omit the entries—
“Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994”,
“Medicines (Advertising) Regulations 1994”,
“Medicines (Monitoring of Advertising) Regulations 1994”,
“Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994”,
“Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005”, and
“Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012”.
(3) In Part 3 under the heading “Public health and safety”—
(a)omit the entries—
“Medicines (Advertising) Amendment Regulations 2004”, and
“Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012, in relation to Part 7 (traditional herbal registrations) of those Regulations”.
(4) In Part 6—
(a)omit the entry—
“Medicines (Advertising) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012, in relation to Chapters 1 and 2 of Part 14 (advertising) of those Regulations”.
(5) In Part 8—
(a)omit the entry—
“Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012, in relation to Part 7 (traditional herbal registrations) of those Regulations”.
(6) In Part 13—
(a)omit the entry—
“Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012, in relation to Part 7 (traditional herbal registrations) of those Regulations”.
Marginal Citations
M26S.I. 2007/3544, as amended by S.I. 2009/2981. There are other amendments, but none is relevant.
94. In paragraph (d) of article 3 of the Medicines for Human Use (Prohibition) (Senecio and Miscellaneous Amendments) Order 2008 M27, for the words following “subject” to the end of the article substitute “ of a marketing authorisation, certificate of registration, traditional herbal registration or Article 126a authorisation within the meaning of the Human Medicines Regulations 2012. ”.U.K.
Marginal Citations
95. In article 5(2) of the Specified Animal Pathogens Order 2008 M28—U.K.
(a)in sub-paragraph (b) for “the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994” substitute “ the Human Medicines Regulations 2012 ”; and
(b)omit sub-paragraph (c).
Marginal Citations
M28S.I. 2008/944. There are amendments, but none is relevant.
96. In article 5(2) of the Specified Animal Pathogens (Wales) Order 2008 M29—U.K.
(a)in sub-paragraph (b) for “the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994” substitute “ the Human Medicines Regulations 2012 ”; and
(b)omit sub-paragraph (c).
Marginal Citations
M29S.I. 2008/1270. There are amendments, but none is relevant.
97. In regulation 1(2) of the Health Service Branded Medicines (Control of Prices and Supply of Information) (No 2) Regulations 2008 M30 in the definition “prescription only medicine”, for “the Prescription Only Medicines (Human Use) Order 1997” substitute “ the Human Medicines Regulations 2012 ”.U.K.
Marginal Citations
M30S.I. 2008/3258. There are amendments, but none is relevant.
98. In article 5(2) of the Specified Animal Pathogens (Scotland) Order 2009 M31—U.K.
(a)in sub-paragraph (b) for “the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994;” substitute “ the Human Medicines Regulations 2012. ”; and
(b)omit sub-paragraph (c).
Marginal Citations
M31S.S.I. 2009/45. There are amendments, but none is relevant.
99.—(1) The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009 M32 are amended as follows.U.K.
(2) In regulation 2(1)—
(a)in the definition “clinical management plan” for the words from “article” to the end of the definition substitute “ regulation 8(1) of the Human Medicines Regulations 2012 ”;
(b)in the definition “non-proprietary name”—
(i)for “section 103(5) of the 1968 Act” in both places where it occurs substitute “regulation 321(3) of the Human Medicines Regulations 2012, and
(ii)for “section 100 of that Act” substitute “ regulation 318 of those Regulations ”;
(c)in the definition “Patient Group Direction” for the words from “Article” to the end of the definition substitute “ regulation 213 of the Human Medicines Regulations 2012 ”; and
(d)in the definition “supply form” for the words from “Article” to the end of the definition substitute “ regulation 233 (exemption for supply etc under a PGD by person conducting a retail pharmacy business) of the Human Medicines Regulations 2012 ”.
(3) In Schedule 1—
(a)in paragraph 4—
(i)in sub-paragraph (23) for “Article 12C of the Prescription Only Medicines (Human Use) Order 1997 (exemption for persons conducting a retail pharmacy business who supply or administer prescription only medicines under a Patient Group Direction)” substitute “ regulation 233 (exemption for supply etc under a PGD by person conducting a retail pharmacy business) of the Human Medicines Regulations 2012 ”; and
(ii)in sub-paragraph (29) for “paragraph (4) of article 8 of the Prescription Only Medicines (Human Use) Order 1997” substitute “ regulation 225 (emergency sale etc by pharmacist: at patient's request) of the Human Medicines Regulations 2012 ”; and
(b)in paragraph 10(8) for “article 12C of the Prescription Only Medicines (Human Use) Order 1997, (exemption for persons conducting a retail pharmacy business who supply or administer prescription only medicines under a Patient Group Direction)” substitute “ regulation 233 (exemption for supply etc under a PGD by person conducting a retail pharmacy business) of the Human Medicines Regulations 2012, ”.
Marginal Citations
100.—(1) The Co-ordination of Regulatory Enforcement (Regulatory Functions in Scotland and Northern Ireland) Order 2009 M33 is amended as follows.U.K.
(2) In Part 1 of Schedule 1, to the entry “Medicines Act 1968 (section 109)” add “or Human Medicines Regulations 2012 (regulation 323)”.
(3) In Part 2 of Schedule 1—
(a)omit the entry—
“Medicines (Advertising) Regulations 1994”; and
(b)add in the appropriate place the entry—
“Human Medicines Regulations 2012, in relation to Chapters 1 and 2 of Part 14 (advertising) of those Regulations”.
(4) In Part 4 of Schedule 1—
(a)omit the entry—
“Medicines (Traditional Herbal Medicinal Products for human use) Regulations 2005”; and
(b)add in the appropriate place the entry—
“Human Medicines Regulations 2012, in relation to Part 7 (traditional herbal registrations) of those Regulations”.
(5) In Part 2 of Schedule 2—
(a)omit the entry—
“Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005”; and
(b)add the entry—
“Human Medicines Regulations 2012, in relation to Part 7 (traditional herbal registrations) of those Regulations”.
Marginal Citations
M33S.I. 2009/669. There are amendments, but none is relevant.
101. In Schedule 1(3) to the Single Use Carrier Bags Charge (Wales) Regulations 2010 M34—U.K.
(a)in the definition “EEA health professional” for the words from “1(2)” to the end of the definition substitute “ 213(1) of the Human Medicines Regulations 2012 ”;
(b)in the definition “pharmacy medicine” for the words from “means” to the end of the definition substitute “ has the meaning given in regulation 5(5) of the Human Medicines Regulations 2012 ”;
(c)in the definition “prescription only medicine” for the words from “means” to the end of the definition substitute “ has the meaning given in regulation 5(3) of the Human Medicines Regulations 2012 ”; and
(d)in the definition beginning “supplementary prescriber” for “article 1(2) of the Prescription Only Medicines (Human Use) Order 1997” substitute “ regulation 8(1) of the Human Medicines Regulations 2012 ”.
Marginal Citations
M34S.I. 2010/2880. There are amendments, but none is relevant.